$HAE
HAEMONETICS CORP

2021 Q1 Form 10-Q Financial Statement

#000031314321000010 Filed on February 02, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q4 2019 Q4
Revenue $240.4M $259.0M
YoY Change -7.18% 4.7%
Cost Of Revenue $120.1M $130.9M
YoY Change -8.25% -3.86%
Gross Profit $120.3M $128.1M
YoY Change -6.09% 15.18%
Gross Profit Margin 50.03% 49.45%
Selling, General & Admin $65.64M $78.27M
YoY Change -16.13% 5.94%
% of Gross Profit 54.58% 61.12%
Research & Development $7.501M $7.000M
YoY Change 7.16% -22.03%
% of Gross Profit 6.24% 5.47%
Depreciation & Amortization $20.80M $27.00M
YoY Change -22.96% -3.23%
% of Gross Profit 17.3% 21.09%
Operating Expenses $79.83M $87.14M
YoY Change -8.39% 5.18%
Operating Profit $40.43M $40.91M
YoY Change -1.18% 44.45%
Interest Expense -$3.100M -$3.100M
YoY Change 0.0% 6.9%
% of Operating Profit -7.67% -7.58%
Other Income/Expense, Net -$3.051M -$3.078M
YoY Change -0.88% 7.7%
Pretax Income $37.37M $37.83M
YoY Change -1.2% 48.57%
Income Tax $5.500M $7.900M
% Of Pretax Income 14.72% 20.88%
Net Earnings $31.88M $29.90M
YoY Change 6.65% -452.58%
Net Earnings / Revenue 13.26% 11.54%
Basic Earnings Per Share $0.63 $0.59
Diluted Earnings Per Share $0.62 $0.58
COMMON SHARES
Basic Shares Outstanding 50.82M shares 50.79M shares 50.63M shares
Diluted Shares Outstanding 51.36M shares 51.64M shares

Balance Sheet

Concept 2021 Q1 2020 Q4 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $189.0M $126.4M
YoY Change 49.53% -18.4%
Cash & Equivalents $189.0M $126.4M
Short-Term Investments
Other Short-Term Assets $32.70M $31.20M
YoY Change 4.81% 27.35%
Inventory $299.7M $254.2M
Prepaid Expenses
Receivables $146.9M $170.8M
Other Receivables $0.00 $0.00
Total Short-Term Assets $668.3M $582.6M
YoY Change 14.72% 12.92%
LONG-TERM ASSETS
Property, Plant & Equipment $240.0M $268.1M
YoY Change -10.48% -23.64%
Goodwill $215.5M $211.1M
YoY Change 2.11% 0.16%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $69.93M $64.27M
YoY Change 8.8% 459.72%
Total Long-Term Assets $649.7M $655.2M
YoY Change -0.83% -7.95%
TOTAL ASSETS
Total Short-Term Assets $668.3M $582.6M
Total Long-Term Assets $649.7M $655.2M
Total Assets $1.318B $1.238B
YoY Change 6.49% 0.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $42.98M $52.30M
YoY Change -17.82% -16.43%
Accrued Expenses $35.10M $50.40M
YoY Change -30.36% -2.7%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $17.06M $61.97M
YoY Change -72.48% 260.29%
Total Short-Term Liabilities $194.4M $256.7M
YoY Change -24.27% 21.49%
LONG-TERM LIABILITIES
Long-Term Debt $292.7M $309.7M
YoY Change -5.49% -5.17%
Other Long-Term Liabilities $102.0M $82.16M
YoY Change 24.15% 191.7%
Total Long-Term Liabilities $394.7M $391.9M
YoY Change 0.72% 10.46%
TOTAL LIABILITIES
Total Short-Term Liabilities $194.4M $256.7M
Total Long-Term Liabilities $394.7M $391.9M
Total Liabilities $589.1M $648.6M
YoY Change -9.17% 14.58%
SHAREHOLDERS EQUITY
Retained Earnings $169.0M $69.87M
YoY Change 141.92% -50.3%
Common Stock $580.0M $538.4M
YoY Change 7.72% 1.27%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $719.2M $574.6M
YoY Change
Total Liabilities & Shareholders Equity $1.318B $1.238B
YoY Change 6.49% 0.82%

Cashflow Statement

Concept 2021 Q1 2020 Q4 2019 Q4
OPERATING ACTIVITIES
Net Income $31.88M $29.90M
YoY Change 6.65% -452.58%
Depreciation, Depletion And Amortization $20.80M $27.00M
YoY Change -22.96% -3.23%
Cash From Operating Activities $66.30M $79.30M
YoY Change -16.39% 36.49%
INVESTING ACTIVITIES
Capital Expenditures -$9.400M -$20.40M
YoY Change -53.92% -30.14%
Acquisitions
YoY Change
Other Investing Activities -$200.0K $600.0K
YoY Change -133.33% -62.5%
Cash From Investing Activities -$9.500M -$19.80M
YoY Change -52.02% -28.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -149.9M -46.20M
YoY Change 224.46% -39.37%
NET CHANGE
Cash From Operating Activities 66.30M 79.30M
Cash From Investing Activities -9.500M -19.80M
Cash From Financing Activities -149.9M -46.20M
Net Change In Cash -93.10M 13.30M
YoY Change -800.0% -129.1%
FREE CASH FLOW
Cash From Operating Activities $66.30M $79.30M
Capital Expenditures -$9.400M -$20.40M
Free Cash Flow $75.70M $99.70M
YoY Change -24.07% 14.2%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0000313143
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--04-03
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2525000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
240371000 USD
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
258970000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
645434000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
749987000 USD
CY2020Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
120114000 USD
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3824000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
309951000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
296942000 USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50817233 shares
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50322930 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50817233 shares
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50322930 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-12-26
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-14041
dei Entity Registrant Name
EntityRegistrantName
HAEMONETICS CORP
CY2019Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
130920000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
329403000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
379031000 USD
dei City Area Code
CityAreaCode
781
dei Local Phone Number
LocalPhoneNumber
848-7100
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MA
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-2882273
dei Entity Address Address Line1
EntityAddressAddressLine1
125 Summer Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Boston,
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02110
dei Security12b Title
Security12bTitle
Common stock, $.01 par value per share
dei Trading Symbol
TradingSymbol
HAE
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
50821698 shares
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22014000 USD
CY2020Q4 us-gaap Gross Profit
GrossProfit
120257000 USD
CY2019Q4 us-gaap Gross Profit
GrossProfit
128050000 USD
us-gaap Gross Profit
GrossProfit
316031000 USD
us-gaap Gross Profit
GrossProfit
370956000 USD
CY2020Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7501000 USD
CY2019Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7000000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21909000 USD
CY2020Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
73446000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
229189000 USD
CY2020Q4 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
0 USD
CY2019Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
78267000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
214680000 USD
CY2019Q4 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
1876000 USD
us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
1028000 USD
us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
50597000 USD
CY2020Q4 hae Gain Loss On Divestiture And Sale Of Assets
GainLossOnDivestitureAndSaleOfAssets
1115000 USD
CY2019Q4 hae Gain Loss On Divestiture And Sale Of Assets
GainLossOnDivestitureAndSaleOfAssets
0 USD
hae Gain Loss On Divestiture And Sale Of Assets
GainLossOnDivestitureAndSaleOfAssets
32613000 USD
hae Gain Loss On Divestiture And Sale Of Assets
GainLossOnDivestitureAndSaleOfAssets
8083000 USD
CY2020Q4 us-gaap Operating Expenses
OperatingExpenses
79832000 USD
CY2019Q4 us-gaap Operating Expenses
OperatingExpenses
87143000 USD
us-gaap Operating Expenses
OperatingExpenses
205109000 USD
us-gaap Operating Expenses
OperatingExpenses
293612000 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
40425000 USD
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
40907000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
110922000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
77344000 USD
CY2020Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3051000 USD
CY2019Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3078000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-10612000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-12152000 USD
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
37374000 USD
CY2019Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
37829000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
100310000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
65192000 USD
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5492000 USD
CY2019Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7934000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9800000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6290000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
31882000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
29895000 USD
us-gaap Net Income Loss
NetIncomeLoss
90510000 USD
us-gaap Net Income Loss
NetIncomeLoss
58902000 USD
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.63
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.79
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.16
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.62
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.77
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.13
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50789000 shares
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50630000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50634000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50810000 shares
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51363000 shares
CY2019Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51638000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51234000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51995000 shares
CY2020Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
40496000 USD
CY2019Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
32296000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
105787000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
55577000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
189002000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
137311000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
146939000 USD
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
165207000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
299710000 USD
CY2020Q1 us-gaap Inventory Net
InventoryNet
270276000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
32697000 USD
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
30845000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
668348000 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
603639000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
240009000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
253399000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
119716000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
133106000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
215508000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
210652000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
4558000 USD
CY2020Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
3930000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
69929000 USD
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
62384000 USD
CY2020Q4 us-gaap Assets
Assets
1318068000 USD
CY2020Q1 us-gaap Assets
Assets
1267110000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
17055000 USD
CY2020Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
76980000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
42979000 USD
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
50730000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
35127000 USD
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
49471000 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
99223000 USD
CY2020Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
97641000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
194384000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
274822000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
292721000 USD
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
305513000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
9803000 USD
CY2020Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
10562000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
102008000 USD
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
89104000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
508000 USD
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
503000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
579480000 USD
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
553229000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
169022000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
78512000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-29858000 USD
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-45135000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
719152000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
587109000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1318068000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1267110000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
587109000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2144000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1193000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6167000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
10527000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1429000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
608569000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
67000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5952000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
48101000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
5234000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
667923000 USD
CY2020Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1868000 USD
CY2020Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2578000 USD
CY2020Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6287000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
31882000 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
8614000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
719152000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
667868000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1830000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3635000 USD
CY2019Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
75000000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4730000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-8479000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3618000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
590966000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2410000 USD
CY2019Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
50000000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5000000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
37486000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2108000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
583754000 USD
CY2019Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1538000 USD
CY2019Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1667000 USD
CY2019Q4 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
50000000 USD
CY2019Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2019Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5325000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
29895000 USD
CY2019Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2401000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
574580000 USD
us-gaap Net Income Loss
NetIncomeLoss
90510000 USD
us-gaap Net Income Loss
NetIncomeLoss
58902000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
62377000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
81524000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
1028000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
50597000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
18406000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
15055000 USD
us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
-3953000 USD
us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
-4747000 USD
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
2942000 USD
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-2246000 USD
hae Gain Loss On Divestiture And Sale Of Assets
GainLossOnDivestitureAndSaleOfAssets
32613000 USD
hae Gain Loss On Divestiture And Sale Of Assets
GainLossOnDivestitureAndSaleOfAssets
8083000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
1351000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
1945000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-18588000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-13807000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
33728000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
68251000 USD
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-1181000 USD
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
273000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-2687000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
8829000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-21518000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-17590000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
107258000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
111811000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25408000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
38112000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
16606000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
44587000 USD
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
9808000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1085000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
16263000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3658000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12041000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-60000000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
30000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
13125000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
8750000 USD
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
0 USD
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
175000000 USD
us-gaap Employee Stock Ownership Plan Esop Cash Contributions To Esop
EmployeeStockOwnershipPlanESOPCashContributionsToESOP
4012000 USD
us-gaap Employee Stock Ownership Plan Esop Cash Contributions To Esop
EmployeeStockOwnershipPlanESOPCashContributionsToESOP
3368000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3838000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7712000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-32000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
90000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-65307000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-142580000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6082000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-124000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
51691000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-42934000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
137311000 USD
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
169351000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
189002000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
126417000 USD
us-gaap Interest Paid Net
InterestPaidNet
6070000 USD
us-gaap Interest Paid Net
InterestPaidNet
10739000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5612000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
9888000 USD
hae Transfers From Inventory To Fixed Assets
TransfersFromInventoryToFixedAssets
5878000 USD
hae Transfers From Inventory To Fixed Assets
TransfersFromInventoryToFixedAssets
10705000 USD
CY2020Q1 us-gaap Restructuring Reserve
RestructuringReserve
2648000 USD
us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
5100000 USD
us-gaap Restructuring Charges
RestructuringCharges
900000 USD
us-gaap Payments For Restructuring
PaymentsForRestructuring
2433000 USD
CY2020Q4 us-gaap Restructuring Reserve
RestructuringReserve
1115000 USD
CY2020Q4 us-gaap Restructuring Charges
RestructuringCharges
-92000 USD
CY2019Q4 us-gaap Restructuring Charges
RestructuringCharges
617000 USD
us-gaap Restructuring Charges
RestructuringCharges
900000 USD
us-gaap Restructuring Charges
RestructuringCharges
2929000 USD
CY2020Q4 us-gaap Restructuring Reserve
RestructuringReserve
1100000 USD
CY2020Q4 hae Restructuring Charges Payable In Next Twelve Months
RestructuringChargesPayableInNextTwelveMonths
700000 USD
CY2020Q4 us-gaap Restructuring Charges
RestructuringCharges
-92000 USD
CY2019Q4 us-gaap Restructuring Charges
RestructuringCharges
617000 USD
us-gaap Restructuring Charges
RestructuringCharges
900000 USD
us-gaap Restructuring Charges
RestructuringCharges
2929000 USD
CY2020Q4 hae Restructuring Related Costs
RestructuringRelatedCosts
3235000 USD
CY2019Q4 hae Restructuring Related Costs
RestructuringRelatedCosts
7181000 USD
hae Restructuring Related Costs
RestructuringRelatedCosts
10683000 USD
CY2019Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7900000 USD
hae Restructuring Related Costs
RestructuringRelatedCosts
10653000 USD
CY2020Q4 hae Restructuringand Restructuring Related Costs
RestructuringandRestructuringRelatedCosts
3143000 USD
CY2019Q4 hae Restructuringand Restructuring Related Costs
RestructuringandRestructuringRelatedCosts
7798000 USD
hae Restructuringand Restructuring Related Costs
RestructuringandRestructuringRelatedCosts
11583000 USD
hae Restructuringand Restructuring Related Costs
RestructuringandRestructuringRelatedCosts
13582000 USD
CY2020Q4 us-gaap Business Combination Separately Recognized Transactions Additional Disclosures Acquisition Cost Expensed
BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed
200000 USD
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5500000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9800000 USD
CY2020Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.147
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.098
CY2020Q4 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
1000000.0 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.79
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.16
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6300000 USD
CY2019Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.210
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.096
CY2019Q4 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
3100000 USD
us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
12400000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
31882000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
29895000 USD
us-gaap Net Income Loss
NetIncomeLoss
90510000 USD
us-gaap Net Income Loss
NetIncomeLoss
58902000 USD
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50789000 shares
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50630000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50634000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50810000 shares
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.63
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
31882000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
29895000 USD
us-gaap Net Income Loss
NetIncomeLoss
90510000 USD
us-gaap Net Income Loss
NetIncomeLoss
58902000 USD
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50789000 shares
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50630000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50634000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50810000 shares
CY2020Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
574000 shares
CY2019Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1008000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
600000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1185000 shares
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51363000 shares
CY2019Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51638000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51234000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51995000 shares
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.62
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
200000 shares
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.77
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.13
CY2020Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
400000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
600000 shares
CY2020Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
17900000 USD
CY2020Q4 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.59
CY2020Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2020Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
5400000 USD
CY2020Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
5000000.0 USD
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
16700000 USD
CY2020Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
20800000 USD
CY2020Q4 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2500000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
16300000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2500000 USD
CY2020Q4 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2500000 USD
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
74437000 USD
CY2020Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
76867000 USD
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
22030000 USD
CY2020Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
11021000 USD
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
203243000 USD
CY2020Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
182388000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
299710000 USD
CY2020Q1 us-gaap Inventory Net
InventoryNet
270276000 USD
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2699000 USD
CY2019Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4108000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3824000 USD
CY2019Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3937000 USD
CY2020Q4 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
95000 USD
CY2019Q4 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-229000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
838000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-515000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
79000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
240000 USD
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
461000 USD
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
355000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2525000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4097000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2525000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4097000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 segment
CY2019Q4 hae Net Revenues Before Foreign Exchange Impact
NetRevenuesBeforeForeignExchangeImpact
257064000 USD
hae Net Revenues Before Foreign Exchange Impact
NetRevenuesBeforeForeignExchangeImpact
632960000 USD
CY2020Q4 hae Net Revenues Before Foreign Exchange Impact
NetRevenuesBeforeForeignExchangeImpact
234905000 USD
hae Net Revenues Before Foreign Exchange Impact
NetRevenuesBeforeForeignExchangeImpact
742720000 USD
CY2020Q4 hae Effectof Exchange Rateon Revenues
EffectofExchangeRateonRevenues
494000 USD
CY2019Q4 hae Effectof Exchange Rateon Revenues
EffectofExchangeRateonRevenues
-3291000 USD
hae Effectof Exchange Rateon Revenues
EffectofExchangeRateonRevenues
-2922000 USD
hae Effectof Exchange Rateon Revenues
EffectofExchangeRateonRevenues
-8072000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
240371000 USD
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
258970000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
645434000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
749987000 USD
CY2020Q4 hae Effectof Exchange Rateson Operating Income
EffectofExchangeRatesonOperatingIncome
4286000 USD
CY2019Q4 hae Effectof Exchange Rateson Operating Income
EffectofExchangeRatesonOperatingIncome
2521000 USD
hae Effectof Exchange Rateson Operating Income
EffectofExchangeRatesonOperatingIncome
8644000 USD
hae Effectof Exchange Rateson Operating Income
EffectofExchangeRatesonOperatingIncome
7791000 USD
CY2019Q4 us-gaap Adjustment For Amortization
AdjustmentForAmortization
5772000 USD
CY2020Q4 us-gaap Adjustment For Amortization
AdjustmentForAmortization
7805000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
24204000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
17681000 USD
CY2020Q4 hae Restructuringand Turnaround Costs
RestructuringandTurnaroundCosts
3143000 USD
CY2019Q4 hae Restructuringand Turnaround Costs
RestructuringandTurnaroundCosts
7798000 USD
hae Restructuringand Turnaround Costs
RestructuringandTurnaroundCosts
11583000 USD
hae Restructuringand Turnaround Costs
RestructuringandTurnaroundCosts
13582000 USD
CY2020Q4 hae Operating Expenses Transaction Costs
OperatingExpensesTransactionCosts
0 USD
CY2019Q4 hae Operating Expenses Transaction Costs
OperatingExpensesTransactionCosts
0 USD
hae Operating Expenses Transaction Costs
OperatingExpensesTransactionCosts
3063000 USD
hae Operating Expenses Transaction Costs
OperatingExpensesTransactionCosts
0 USD
CY2020Q4 us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
1146000 USD
CY2019Q4 us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
6649000 USD
us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
3332000 USD
us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
18708000 USD
CY2020Q4 hae European Medical Device Regulation Costs
EuropeanMedicalDeviceRegulationCosts
1207000 USD
CY2019Q4 hae European Medical Device Regulation Costs
EuropeanMedicalDeviceRegulationCosts
448000 USD
hae European Medical Device Regulation Costs
EuropeanMedicalDeviceRegulationCosts
2696000 USD
hae European Medical Device Regulation Costs
EuropeanMedicalDeviceRegulationCosts
304000 USD
CY2020Q4 hae Asset Impairment And Other Related Charges
AssetImpairmentAndOtherRelatedCharges
0 USD
CY2019Q4 hae Asset Impairment And Other Related Charges
AssetImpairmentAndOtherRelatedCharges
0 USD
hae Asset Impairment And Other Related Charges
AssetImpairmentAndOtherRelatedCharges
896000 USD
hae Asset Impairment And Other Related Charges
AssetImpairmentAndOtherRelatedCharges
51220000 USD
CY2020Q4 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
1115000 USD
CY2019Q4 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
32613000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
8083000 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
40425000 USD
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
40907000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
110922000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
77344000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
240371000 USD
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
258970000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
645434000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
749987000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
240371000 USD
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
258970000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
645434000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
749987000 USD
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-45135000 USD
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
10413000 USD
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-4864000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
15277000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-29858000 USD

Files In Submission

Name View Source Status
0000313143-21-000010-index-headers.html Edgar Link pending
0000313143-21-000010-index.html Edgar Link pending
0000313143-21-000010.txt Edgar Link pending
0000313143-21-000010-xbrl.zip Edgar Link pending
ex101-firstamendmenttoclin.htm Edgar Link pending
ex102-12thamendmenttoleets.htm Edgar Link pending
ex103-13thamendmenttoleets.htm Edgar Link pending
ex104-agreementandplanofme.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hae-20201226.htm Edgar Link pending
hae-20201226.xsd Edgar Link pending
hae-20201226_cal.xml Edgar Link unprocessable
hae-20201226_def.xml Edgar Link unprocessable
hae-20201226_htm.xml Edgar Link completed
hae-20201226_lab.xml Edgar Link unprocessable
hae-20201226_pre.xml Edgar Link unprocessable
haeq3dec2021ex311.htm Edgar Link pending
haeq3dec2021ex312.htm Edgar Link pending
haeq3dec2021ex321.htm Edgar Link pending
haeq3dec2021ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending